Multicenter Evaluation of the In Vitro Activity of Six Broad-Spectrum β-Lactam Antimicrobial Agents in Puerto Rico
- 28 February 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 30 (2) , 113-119
- https://doi.org/10.1016/s0732-8893(97)00160-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- CefepimeMedical Clinics of North America, 1995
- Antimicrobial activity of cefepime tested against bush group I β-lactamase-producing strains resistant to ceftazidime a multilaboratory national and international clinical isolate studyDiagnostic Microbiology and Infectious Disease, 1994
- CefepimeDrugs, 1994
- Cefepime: overview of activity in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1993
- Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutationsJournal of Antimicrobial Chemotherapy, 1993
- Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1992
- Evaluation of the E test, a novel method of quantifying antimicrobial activityJournal of Antimicrobial Chemotherapy, 1991
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990
- Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsAntimicrobial Agents and Chemotherapy, 1989
- Activity of cefepime (BMY-28142) and cefpirome (HR 810) against Gram-negatire bacilli resistant to cefotaxime or ceftaxidimeJournal of Antimicrobial Chemotherapy, 1989